ALRN Insider Trading

Insider Ownership Percentage: 5.10%
Insider Buying (Last 12 Months): $896.00
Insider Selling (Last 12 Months): $248,684.90

Aileron Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Aileron Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aileron Therapeutics Share Price & Price History

Current Price: $2.25
Price Change: Price Increase of +0.08 (3.69%)
As of 12/26/2024 06:36 PM ET

This chart shows the closing price history over time for ALRN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Aileron Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/5/2024James Brian WindsorCEOBuy400$2.24$896.00239View SEC Filing Icon  
6/17/2024Of Texas/Texas Am I UniversityMajor ShareholderSell4,707$3.25$15,297.751,746,549View SEC Filing Icon  
6/14/2024Of Texas/Texas Am I UniversityMajor ShareholderSell1,900$3.30$6,270.001,751,256View SEC Filing Icon  
6/12/2024Of Texas/Texas Am I UniversityMajor ShareholderSell9,342$3.25$30,361.501,753,156View SEC Filing Icon  
6/10/2024Of Texas/Texas Am I UniversityMajor ShareholderSell9,577$3.30$31,604.101,768,250View SEC Filing Icon  
6/7/2024Of Texas/Texas Am I UniversityMajor ShareholderSell1,740$3.26$5,672.401,777,827View SEC Filing Icon  
6/5/2024Of Texas/Texas Am I UniversityMajor ShareholderSell6,291$3.30$20,760.301,783,851View SEC Filing Icon  
5/1/2024Of Texas/Texas Am I UniversityMajor ShareholderSell20,315$4.21$85,526.151,779,306View SEC Filing Icon  
4/29/2024Of Texas/Texas Am I UniversityMajor ShareholderSell10,746$4.95$53,192.701,799,711View SEC Filing Icon  
12/15/2023James Brian WindsorCOOBuy225$3.37$758.25225View SEC Filing Icon  
11/20/2023James Brian WindsorCOOBuy5,076$1.97$9,999.725,122View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Aileron Therapeutics (NASDAQ:ALRN)

90.89% of Aileron Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ALRN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Aileron Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2024Geode Capital Management LLC229,817$0.81M0.0%+34.8%1.061%Search for SEC Filing on Google Icon
11/4/2024Sigma Planning Corp212,410$0.75M0.0%+68.3%0.980%Search for SEC Filing on Google Icon
10/29/2024KG&L Capital Management LLC13,000$46K0.0%N/A0.060%Search for SEC Filing on Google Icon
9/17/2024University of Texas Texas AM Investment Management Co.1,777,827$4.93M1.0%N/A8.225%Search for SEC Filing on Google Icon
8/20/2024Nantahala Capital Management LLC464,367$1.29M0.1%+82.1%2.148%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC24,864$69K0.0%-44.8%0.115%Search for SEC Filing on Google Icon
8/9/2024Warberg Asset Management LLC31,354$86K0.0%N/A0.145%Search for SEC Filing on Google Icon
8/2/2024University of Texas Texas AM Investment Management Co.1,777,827$4.93M1.9%N/A8.225%Search for SEC Filing on Google Icon
5/13/2024Texas Capital Bank Wealth Management Services Inc26,171$0.17M0.0%+65.9%0.155%Search for SEC Filing on Google Icon
2/8/2024Texas Capital Bank Wealth Management Services Inc15,773$48K0.0%N/A0.323%Search for SEC Filing on Google Icon
2/1/2024Sigma Planning Corp16,580$51K0.0%N/A0.339%Search for SEC Filing on Google Icon
2/15/2023Alerce Investment Management L.P.830,466$1.97M2.3%-95.0%18.288%Search for SEC Filing on Google Icon
2/10/2023Blair William & Co. IL67,867$0.16M0.0%-94.5%1.495%Search for SEC Filing on Google Icon
1/31/2023KCK LTD.22,341$53K0.1%-95.0%0.492%Search for SEC Filing on Google Icon
10/31/2022KCK LTD.446,817$0.10M0.2%-30.9%0.492%Search for SEC Filing on Google Icon
4/25/2022Bailard Inc.128,010$66K0.0%N/A0.141%Search for SEC Filing on Google Icon
2/14/2022Blair William & Co. IL1,067,489$0.60M0.0%+32.9%1.179%Search for SEC Filing on Google Icon
2/11/2022KCK LTD.646,817$0.36M0.3%N/A0.714%Search for SEC Filing on Google Icon
2/10/2022Acadian Asset Management LLC85,274$47K0.0%N/A0.094%Search for SEC Filing on Google Icon
2/4/2022Envestnet Asset Management Inc.136,760$77K0.0%+152.4%0.151%Search for SEC Filing on Google Icon
2/2/2022PVG Asset Management Corp50,300$28K0.1%+113.5%0.056%Search for SEC Filing on Google Icon
1/27/2022Morgan Jess S & Co. Inc.100,000$56K0.0%+33.3%0.110%Search for SEC Filing on Google Icon
11/16/2021Keebeck Wealth Management LLC76,000$78K0.0%-51.2%0.084%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC734,721$0.75M0.0%-28.7%0.811%Search for SEC Filing on Google Icon
11/9/2021Morgan Jess S & Co. Inc.75,000$76K0.1%N/A0.083%Search for SEC Filing on Google Icon
11/9/2021Barclays PLC25,279$26K0.0%+235.4%0.028%Search for SEC Filing on Google Icon
11/9/2021JFS Wealth Advisors LLC31,807$32K0.0%N/A0.035%Search for SEC Filing on Google Icon
10/26/2021Game Plan Financial Advisors LLC127,000$0.13M0.1%+27.0%0.140%Search for SEC Filing on Google Icon
8/17/2021Boothbay Fund Management LLC393,015$0.49M0.0%+11.8%0.434%Search for SEC Filing on Google Icon
8/16/2021State Street Corp71,200$89K0.0%N/A0.079%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC1,031,128$1.29M0.0%-17.5%1.142%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC766,813$0.96M0.0%+34.1%0.849%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.3,440,633$4.30M0.0%-5.9%3.809%Search for SEC Filing on Google Icon
8/12/2021Blair William & Co. IL688,044$0.86M0.0%+99.1%0.762%Search for SEC Filing on Google Icon
8/4/2021Envestnet Asset Management Inc.34,654$43K0.0%+45.1%0.038%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC46,830$67K0.0%N/A0.052%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC146,341$0.21M0.0%+746.6%0.162%Search for SEC Filing on Google Icon
5/18/2021BVF Inc. IL5,265,555$7.53M0.3%N/A5.829%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC46,830$67K0.0%N/A0.052%Search for SEC Filing on Google Icon
5/17/2021Ikarian Capital LLC2,800,000$4M0.1%N/A3.100%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC1,250,500$1.79M0.0%+97.1%1.385%Search for SEC Filing on Google Icon
5/13/2021Blair William & Co. IL345,594$0.49M0.0%+29.0%0.383%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp127,883$0.18M0.0%+378.0%0.142%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC571,738$0.82M0.0%+149.3%0.633%Search for SEC Filing on Google Icon
5/12/2021Satter Management CO. L.P.16,609,449$23.75M10.5%+118.3%18.394%Search for SEC Filing on Google Icon
5/11/2021Acadian Asset Management LLC134,419$0.19M0.0%+30.8%0.149%Search for SEC Filing on Google Icon
5/5/2021Wade G W & Inc.100,993$0.14M0.0%N/A0.112%Search for SEC Filing on Google Icon
5/4/2021Envestnet Asset Management Inc.23,886$34K0.0%+105.2%0.026%Search for SEC Filing on Google Icon
4/28/2021Game Plan Financial Advisors LLC77,500$0.11M0.1%+13.1%0.086%Search for SEC Filing on Google Icon
2/11/2021Satter Management CO. L.P.7,609,449$7.91M3.1%N/A9.101%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC634,381$0.66M0.0%-47.3%0.759%Search for SEC Filing on Google Icon
2/9/2021Blair William & Co. IL267,994$0.28M0.0%+10.8%0.321%Search for SEC Filing on Google Icon
2/4/2021GSA Capital Partners LLP86,562$90K0.0%N/A0.198%Search for SEC Filing on Google Icon
1/20/2021Kestra Advisory Services LLC30,000$33K0.0%N/A0.068%Search for SEC Filing on Google Icon
1/19/2021Game Plan Financial Advisors LLC68,500$71K0.1%N/A0.156%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Aileron Therapeutics logo
Aileron Therapeutics, Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States. The company's lead product candidate is LTI-03, a peptide, which is in Phase 1b clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF). Its second product candidate is LTI-01, a proenzyme that has completed Phase 1b and Phase 2a clinical trials in LPE patients for the treatment of loculated pleural effusion. The company's pipeline also includes preclinical programs targeting cystic fibrosis and a peptide program focused on the caveolin-1 protein for systemic fibrosis indications. The company was formerly known as Renegade Therapeutics, Inc. and changed its name to Aileron Therapeutics, Inc. in February 2007. Aileron Therapeutics, Inc. was incorporated in 2001 and is headquartered in Austin, Texas.
Read More on Aileron Therapeutics

Today's Range

Now: $2.25
Low: $2.01
High: $2.29

50 Day Range

MA: $2.92
Low: $1.75
High: $4.12

52 Week Range

Now: $2.25
Low: $1.61
High: $7.42

Volume

646,630 shs

Average Volume

79,164 shs

Market Capitalization

$48.75 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.23

Who are the company insiders with the largest holdings of Aileron Therapeutics?

Aileron Therapeutics' top insider shareholders include:
  1. Of Texas/Texas Am I University (Major Shareholder)
  2. James Brian Windsor (COO)
  3. James Brian Windsor (CEO)
Learn More about top insider investors at Aileron Therapeutics.

Who are the major institutional investors of Aileron Therapeutics?

Aileron Therapeutics' top institutional investors include:
  1. Geode Capital Management LLC — 1.06%
  2. Sigma Planning Corp — 0.98%
  3. KG&L Capital Management LLC — 0.06%
Learn More about top institutional investors of Aileron Therapeutics stock.

Which institutional investors are buying Aileron Therapeutics stock?

During the last quarter, ALRN stock was acquired by institutional investors including:
  1. Sigma Planning Corp
  2. Geode Capital Management LLC
  3. KG&L Capital Management LLC
In the previous year, these company insiders have bought Aileron Therapeutics stock:
  1. Of Texas/Texas Am I University (Major Shareholder)
  2. James Brian Windsor (COO)
Learn More investors buying Aileron Therapeutics stock.